Search details
1.
Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes.
Diabet Med
; 39(9): e14901, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35708737
2.
The relation between the intelligibility of irrelevant speech and cognitive performance-A revised model based on laboratory studies.
Indoor Air
; 30(6): 1130-1146, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32735743
3.
A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes.
Diabetes Obes Metab
; 21(4): 1001-1009, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30552800
4.
EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES.
Endocr Pract
; 25(2): 144-155, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30383495
5.
Auditory distraction by speech: Comparison of fluctuating and steady speech-like masking sounds.
J Acoust Soc Am
; 144(2): EL83, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30180670
6.
Auditory distraction by speech: Sound masking with speech-shaped stationary noise outperforms -5 dB per octave shaped noise.
J Acoust Soc Am
; 143(3): EL212, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29604706
7.
The impact of road traffic noise on cognitive performance in attention-based tasks depends on noise level even within moderate-level ranges.
Noise Health
; 17(76): 148-57, 2015.
Article
in English
| MEDLINE | ID: mdl-25913554
8.
ICBEN review of research on the biological effects of noise 2011-2014.
Noise Health
; 17(75): 57-82, 2015.
Article
in English
| MEDLINE | ID: mdl-25774609
9.
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.
J Diabetes Sci Technol
; : 19322968221149041, 2023 Jan 29.
Article
in English
| MEDLINE | ID: mdl-36710452
10.
Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study).
Diabetes Ther
; 13(1): 175-187, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34918213
11.
[Long-acting insulins in the treatment of type 2 diabetes: a hard choice]. / Welches lang wirksame Insulin passt am besten?
MMW Fortschr Med
; 157(7): 65-8, 2015 Apr 16.
Article
in German
| MEDLINE | ID: mdl-26012462
12.
Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes.
Drugs
; 80(2): 147-165, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31960258
13.
New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion.
J Diabetes Sci Technol
; 13(6): 1158-1160, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31195815
14.
15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes.
Drugs R D
; 18(1): 27-39, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-29468559
15.
[Insulin therapy of type 2 diabetes: from simple to flexible--three strategies are available]. / Insulintherapie bei Typ-2-Diabetes. Von einfach bis flexibel--zur Auswahl stehen drei Strategien.
MMW Fortschr Med
; 154 Spec No 3: 66-71; quiz 72-3, 2012 Nov 08.
Article
in German
| MEDLINE | ID: mdl-23724722
16.
Exploring the characteristics of suboptimally controlled patients after 24weeks of basal insulin treatment: An individualized approach to intensification.
Diabetes Res Clin Pract
; 123: 209-217, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-28061430
17.
SPECTRUM.
J Diabetes Sci Technol
; 11(2): 284-289, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27510443
18.
Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in Germany.
Pharmacoeconomics
; 24 Suppl 1: 35-48, 2006.
Article
in English
| MEDLINE | ID: mdl-16800161
19.
Management of postprandial glucose: Recommended targets and treatment with biphasic insulin.
Prim Care Diabetes
; 10(6): 391-397, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27427307
20.
Efficacy of biphasic insulin aspart in patients with type 2 diabetes.
Clin Ther
; 27 Suppl B: S57-74, 2005.
Article
in English
| MEDLINE | ID: mdl-16519038